HRSA warns Sanofi over 340B rebate proposal

(By Alexandra Murphy for Becker’s Hospital Review)

The Health Resources and Services Administration has issued a warning to Sanofi over its plan to implement a new credit model for sales of certain covered outpatient drugs, threatening to remove the pharmaceutical company from the 340B Drug Pricing Program if the proposal is not halted. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.